In the original version of this article (1), in the Disclosure of Potential Conflicts of Interest section, Dr. Charles S. Fuchs did not report consulting work with the biotechnology and pharmaceutical industry focused on cancer drug development. With respect to an analysis of molecular features that drive sex differences in colorectal cancer development, Dr. Fuchs did not consider that his consulting work in drug development represented a potential conflict of interest or a relevant financial activity to the submitted work. But in the interest of full transparency, Dr. Fuchs has requested that his disclosures be added to the publication. This section has been updated in the latest online HTML and PDF versions of the article.
Reference
- 1.Lopes-Ramos CM, Kuijjer ML, Ogino S, Fuchs CS, DeMeo DL, Glass K, et al. Gene regulatory network analysis identifies sex-linked differences in colon cancer drug metabolism. Cancer Res 2018;78:5538–47. [DOI] [PMC free article] [PubMed] [Google Scholar]